Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia—Therapy and Toxicity Mechanisms

Targeted therapy has revolutionized the treatment of poor-prognosis pediatric acute lymphoblastic leukemia (ALL) with specific genetic abnormalities. It is still being described as a new landmark therapeutic approach. The main purpose of the use of molecularly targeted drugs and immunotherapy in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lejman, Monika, Kuśmierczuk, Kinga, Bednarz, Kinga, Ostapińska, Katarzyna, Zawitkowska, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468873/
https://www.ncbi.nlm.nih.gov/pubmed/34575992
http://dx.doi.org/10.3390/ijms22189827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468873/
https://www.ncbi.nlm.nih.gov/pubmed/34575992
http://dx.doi.org/10.3390/ijms22189827

Ejemplares similares